GA, n = 141 | TEA, n = 147 | P value | |
---|---|---|---|
EUROSCORE II | 3.5 ± 3.8 | 3.65 ± 3.64 | 0.694 |
Age (years) | 66.9 ± 10.9 | 64.3 ± 9.8 | 0.041 |
Height (meters) | 1.70 ± 0.09 | 1.71 ± 0.09 | 0.137 |
Weight (kilograms) | 80.5 ± 16.3 | 82.9 ± 17 | 0.104 |
BSA (m2) | 1.91 ± 0.20 | 1.96 ± 0.21 | 0.064 |
BMI (kg/m2) | 27.8 ± 4.5 | 28.4 ± 5.5 | 0.395 |
Male (female) | 94 (47) | 99 (48) | 0.902 |
CAD | 82 (58.2 %) | 76 (51.7 %) | 0.066 |
Arterial hypertension | 114 (80.9 %) | 109 (74.1 %) | 0.208 |
LV EF (%) | 54.4 ± 12.6 | 56.8 ± 11.2 | 0.044 |
RV dysfunction | 14 (9.9 %) | 15 (10.2 %) | 0.996 |
COPD | 32 (22.7 %) | 40 (27.2 %) | 0.295 |
Diabetes mellitus | 27 (19.1 %) | 38 (25.9 %) | 0.832 |
Stroke/TIA | 15 (10.6 %) | 16 (10.9 %) | 0.946 |
NYHA | 0.370 | ||
I | 10 (7.1 %) | 14 (9.5 %) | |
II | 76 (53.9 %) | 83 (56.5 %) | |
III | 52 (36.9 %) | 46 (31.3 %) | |
IV | 3 (2.1 %) | 4 (2.7 %) | |
Serum creatinine (µmol/L) | 91.6 ± 27.4 | 94.4 ± 35.7 | 0.999 |